View Exam | PowerPak

1. Idiopathic pulmonary fibrosis is identified as an idiopathic interstitial pneumonia. Which of the following histological subtypes is idiopathic pulmonary fibrosis identified as?

A. Acute Interstitial Pneumonia B. Nonspecific Interstitial Pneumonia C. Desquamative Interstitial Pneumonia D. Usual Interstitial Pneumonia

2. The INPULSIS-1 and INPULSIS-2 trials compared the safety and efficacy of nintedanib 150 mg twice daily vs. placebo in patients with idiopathic pulmonary fibrosis. Which of the following statement(s) accurately describe the results?

A. Both trials reduced the annual rate of decline in forced vital capacity B. INPULSIS-2 showed a significant increase in time to first acute exacerbation C. INPULSIS-1 showed a significant increase in time to first acute exacerbation D. Both A and B

3. A 36-year old male patient has been showing clinical symptoms similar to that of IIP for over three months. You suspect they may have idiopathic pulmonary fibrosis. According to current recommendations, which of the following initial diagnostic measures would you order to secure a differential diagnosis?

A. Bronchoscopy only B. Surgical biopsy with HRCT scan C. HRCT scan only D. HRCT scan with a bronchoscopy

4. According to current clinical trial data, pirfenidone vs. placebo was compared in patients with idiopathic pulmonary fibrosis. Which of the following statement(s) accurately describe the effects of pirfenidone?

A. Improved progression free survival B. Showed no significant difference in the annual rate of decline in forced vital capacity C. Showed no significant difference in exercise tolerance D. Dyspepsia was the most common adverse event when compared to placebo

Maintenance is scheduled for 05/16/2024 5:00 PM EST - 05/17/2024 5:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Idiopathic pulmonary fibrosis is identified as an idiopathic interstitial pneumonia. Which of the following histological subtypes is idiopathic pulmonary fibrosis identified as?

2. The INPULSIS-1 and INPULSIS-2 trials compared the safety and efficacy of nintedanib 150 mg twice daily vs. placebo in patients with idiopathic pulmonary fibrosis. Which of the following statement(s) accurately describe the results?

4. According to current clinical trial data, pirfenidone vs. placebo was compared in patients with idiopathic pulmonary fibrosis. Which of the following statement(s) accurately describe the effects of pirfenidone?

« Return to Activity

Maintenance is scheduled for 05/16/2024 5:00 PM EST - 05/17/2024 5:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Idiopathic pulmonary fibrosis is identified as an idiopathic interstitial pneumonia. Which of the following histological subtypes is idiopathic pulmonary fibrosis identified as?

2. The INPULSIS-1 and INPULSIS-2 trials compared the safety and efficacy of nintedanib 150 mg twice daily vs. placebo in patients with idiopathic pulmonary fibrosis. Which of the following statement(s) accurately describe the results?

4. According to current clinical trial data, pirfenidone vs. placebo was compared in patients with idiopathic pulmonary fibrosis. Which of the following statement(s) accurately describe the effects of pirfenidone?

« Return to Activity

Customers who Purchased
this Activity also Purchased